[Federal Register Volume 62, Number 180 (Wednesday, September 17, 1997)]
[Notices]
[Pages 48879-48880]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-24629]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting of the National
Cancer Advisory Board and its Subcommittees
Pursuant to Pub. L. 92-463, as amended, notice is hereby given of
the meeting of the National Cancer Advisory Board (Board), National
Cancer Institute (NCI), and its Subcommittees on September 23-25, 1997.
The meetings of the Board and its Subcommittees will be open to the
public as indicated below. Attendance by the public will be limited to
space available.
A portion of the Board meeting will be closed to the public in
accordance with the provisions set forth in secs. 552b(c)(4),
552b(c)(6), and 552(c)(9)(B), Title 5 U.S.C. and sec. 10(d) of Pub. L.
92-463, for the review, discussion and evaluation of individual grant
applications and for discussion of issues pertaining to programmatic
areas and/or NCI personnel. These applications and discussions could
reveal confidential trade secrets or commercial property such as
patentable material, and personal information concerning the
individuals associated with the applications or programs, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy, and premature disclosure of recommendations which
would be likely to significantly frustrate the subsequent
implementation of those recommendations.
The Committee Management Office, National Cancer Institute,
National Institutes of Health, Executive Plaza North, Room 609, 6130
Executive Boulevard, MSC 7410, Bethesda, Maryland 20892-7410, (301)
496-5708 will provide summaries of the meetings and rosters of the
Board members, upon request.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact Mrs. Linda Quick-Cameron, Committee Management Officer, at
(301) 496-5708 in advance of the meeting.
Name of Committee: Subcommittee on Activities and Agenda.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
5147.
Date of Meeting: September 23, 1997.
Place of Meeting: Bethesda Marriott Hotel (Pooks Hill), 5151
Pooks Hill Road, Bethesda, MD 20814.
Closed: 7:00 p.m. to 9:00 p.m.
Agenda: To Conduct Preliminary Discussion of Future Programmatic
and Personnel Activities and Policies.
Name of Committee: Subcommittee on Planning and Budget.
Contact Person: Ms. Cherie Nichols, Executive Secretary,
National Cancer Institute, NIH, 7550 Wisconsin Avenue, Room 312, MSC
9010, Bethesda, MD 20892-9010, (301) 496-5515.
Date of Meeting: September 24, 1997.
Place of Meeting: Building 31, Conference Room 8/C Wing,
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD
20892.
Open: 12:30 p.m. to 1:30 p.m.
Agenda: To Discuss the NCI Budget and Various Planning Issues.
Name of Committee: Subcommittee on Special Actions for Grants.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD. 20892-7405, (301) 496-
5147.
Date of Meeting: September 24, 1997.
Place of Meeting: Building 31, Conference Room 10/C Wing,
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD.
20892.
Closed: 4:05 p.m. to Adjournment.
Agenda: To Review and Discuss Grant Applications and Extramural/
Intramural, Programmatic and Personnel Policies.
Name of Committee: Subcommittee on Clinical Investigations.
Contact Person: Dr. Robert Wittes, Executive Secretary, National
Cancer Institute, NIH, Building 31, Room 3A44, MSC 2440, 9000
Rockville Pike, Bethesda, MD 20892-2440, (301) 496-4291.
Date of Meeting: September 25, 1997.
Place of Meeting: Building 31, Conference Room 8/C Wing,
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD.
20892.
Open: 12:30 p.m. to 1:45 p.m.
Agenda: To Discuss the Design of Prospective Studies of the
Impact of Managed Care on Cancer Clinical Investigations, Education
and Training.
Name of Committee: National Cancer Advisory Board.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD. 20892-7405, (301) 496-
5147.
Dates of Meeting: September 24-25, 1997.
Place of Meeting: Building 31, Conference Room 10/C Wing,
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD.
20892.
Open: September 24--8:30 a.m. to 4:00 p.m.; September 25--8:30
a.m. to 4:00 p.m.
[[Page 48880]]
Agenda: Report of the Director, National Cancer Institute;
Legislative Update; Report of the President's Cancer Panel; Science
Information System Report; NCAB Policy Statement: Impact of Managed
Care on Cancer Clinical Investigations; Clinical Trials Program
Review Group Report; NCI Exceptions Process; Cancer Control Program
Review Group Report; Reorganization of Extramural Programs & Update
on Centers; NIH & Managed Health Care Organizations; Colorectal
Cancer Screening; GPRA Update for Advisory Councils; Changes in NIH
Rebuttal Policy & NCAB Operating Procedures; Progress Review Groups
Update; NCI Website Demonstrations; Subcommittee Reports and other
Council business.
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the review and funding cycle.
Catalog of Federal Domestic Assistance Program Numbers:
(93.393, Cancer Cause and Prevention Research; 93.392, Cancer
Detection and Diagnosis Research; 93.394, Cancer Treatment Research;
93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control.)
Dated: September 11, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-24629 Filed 9-16-97; 8:45 am]
BILLING CODE 4140-01-M
